Author:
Colazo Juan M.,DeCorte Joseph A.,Gillaspie Erin A.,Folpe Andrew L.,Dahir Kathryn M.
Funder
National Institute of General Medical Sciences
National Institutes of Health
Subject
Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism
Reference33 articles.
1. FGF23 and its role in X-linked hypophosphatemia-related morbidity;Beck-Nielsen;Orphanet Journal of Rare Diseases,2019
2. New perspectives on the biology and treatment of X-linked hypophosphatemic rickets;Carpenter;Pediatr. Clin. N. Am.,1997
3. M. P. Carpenter T.O., Weber T., Peacock M., Ruppe M., Insogna K., Osei S., Luca D., Skrinar A., San Martin J. (2016) Effects of KRN23, and anti-FGF23 antibody, in patients with tumor induced osteomalacia and epidermal nevus syndrome: results from an ongoing phase 2 study. in Jan De Beur S. Annual Meeting of the American Society for Bone and Mineral Research 1098.
4. A novel chromogenic in situ hybridization assay for FGF23 mRNA in phosphaturic mesenchymal tumors;Carter;Am. J. Surg. Pathol.,2015
5. J. M. Colazo, R. C. Thompson, N. V. Covington, K. M. Dahir, An Intracranial Mass Causing Tumor-induced Osteomalacia (TIO): Rapid and Complete Resolution of Severe Osteoporosis After Surgical Resection. doi:https://doi.org/10.1016/j.radcr.2020.01.039.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献